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Assessment of exposure to tobacco smoke: measurement of
exhaled carbon monoxide and hair nicotine
Sibel DORUK1, İbrahim DEMİRTAŞ2, Hüseyin AKŞİT3, Ünal ERKORKMAZ4, Zehra SEYFİKLİ5

Aim: To investigate the effect of tobacco smoke (TS) exposure on the quantity of exhaled carbon monoxide (eCO) and
hair nicotine (HN) and to evaluate the relationship between these values.
Materials and methods: Included in the study were 96 subjects (64 male, 32 female) divided into 3 groups. The subjects
in Group 1 (n = 46) were current smokers, and the subjects in Group 2 (n = 20) and Group 3 (n = 30) were nonsmokers
with or without environmental TS exposure, respectively. The eCO level of all of the subjects was measured with a breath
CO monitor. Gas chromatography/mass spectrometry were used for quantification of the HN (n = 47).
Results: The mean age of the subjects was 39.1 years. The mean levels of eCO were 9.3 ppm, 1.3 ppm, and 1.0 ppm
and the mean HN concentrations were 20.9 ng/mg, 2.1 ng/mg, and 0.7 ng/mg in the 3 groups, respectively. There was
a significant difference between Group 1 and the other groups according to the levels of eCO and HN concentrations,
but the levels of eCO and HN concentrations were similar in Group 2 and Group 3. There was a positive correlation
between the levels of eCO and the HN concentrations. The cutoff values of eCO and HN for smokers were 6 ppm and
4 ng/mg, respectively.
Conclusion: Although nicotine analysis in some biological samples like hair is specific to TS exposure, these methods
are expensive and difficult procedures. Our results suggest that instead of HN analysis, a cheap and easy method like
eCO measurement may be used, but further studies with more cases are needed.
Key words: Environmental tobacco smoke, exhaled carbon monoxide, nicotine, hair nicotine, secondhand smoke,
tobacco smoke

Tütün dumanı maruziyetinin değerlendirilmesi: Soluk havasında karbonmonoksit ve
saçta nikotin ölçümü
Amaç: Tütün dumanı maruziyetinin soluk havasındaki karbonmonoksit (eCO) ve saçtaki nikotin düzeyine etkisini
saptamayı ve bu yöntemler arasındaki ilişkiyi belirlemek.
Yöntem ve gereç: Çalışmaya 3 grup olarak 96 olgu (64/32 erkek/kadın) çalışmaya alındı. Grup 1 (n = 46) sigara içicisi
idi, Grup 2 (n = 20) ve Grup 3 (n = 30) sigara içmeyen ancak çevresel tütün dumanı olan ya da olmayan olgulardı. Tüm
olgularda CO monitörü ile eCO düzeyi ölçüldü. Saçta nikotin konsantrasyonunu belirlemede (n = 47) gaz kromatografi/
kütle spektrometri yöntemi kullanıldı.
Bulgular: Olguların yaş ortalaması 39,1 idi. Ortalama eCO düzeyi gruplarda 9,3 ppm, 1,3 ppm ve 1,0 ppm ve saçta
nikotin konsantrasyonu sırasıyla 20,9 ng/mg, 2,1 ng/mg ve 0,7 ng/mg idi. eCO düzeyleri ve saçta nikotin konsantrasyonu
açısından Grup 1 ile diğer gruplar arasında farklılık saptandı ancak eCO düzeyleri ve saçta nikotin konsantrasyonu.
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Grup 2 ve Grup 3’de benzerdi. eCO düzeyleri ile saç nikotin konsantrasyonları arasında pozitif ilişki saptandı. Sigara
içicilerinde eCO ve saçta nikotin için eşik değerleri sırasıyla 6 ppm ve 4 ng/mg idi.
Sonuç: Saç gibi çeşitli biyolojik örneklerde nikotin analizi tütün dumanı maruziyeti için spesifik olmasına rağmen
bu yöntemler pahalı ve zordur. Sonuçlarımız saç nikotin analizi yerine eCO ölçümü gibi ucuz ve kolay bir yöntemin
kullanabileceğini desteklese de daha fazla sayıda olgu içeren yeni çalışmalara gereksinim vardır.
Anahtar sözcükler: Çevresel tütün dumanı, soluk havası karbonmonoksiti, nikotin, saçta nikotin, pasif içicilik, tütün
dumanı

Introduction
Smoking is the most widespread addiction, affecting
about one-third of the world’s population, and it is
well recognized that cigarette smoking is the primary
preventable cause of death (1-3).
Tobacco smoke (TS) is a complex mixture of
chemicals. Three chemical constituents of TS are
carbon monoxide (CO), hydrogen cyanide, and
nicotine. These chemicals are absorbed and can
be detected as intact compounds or as metabolic
products (4).
CO is one of the most toxic agents in TS and it
is present in mainstream and sidestream smoke.
Exposure to CO can be assessed as CO in expired
alveolar air. The exhaled CO (eCO) is one of the most
commonly used markers to quantify TS exposure.
The most likely cause of high levels of CO exposure
is smoking, and increased levels of eCO reflect the
degree of TS exposure of the lungs. Other factors
leading to CO exposure are environmental pollution,
passive smoking, and occupational exposure (4,5).
Cotinine is the primary metabolite of nicotine
and it can be measured in urine, blood, and saliva.
Urinary measurement is the most useful for the
follow-up of smoking cessation (4,6). The first paper
concerning hair nicotine (HN) determination was
published in 1983 by Ishiyama et al (7). Since then,
the examining of HN content has become a valuable
tool facilitating the assessment of exposure to TS.
HN reflects a gradual accumulation over a long
period. Each centimeter of hair represents about 1
month of cumulative TS exposure (8,9). Although
they are costly and technically difficult methods,
quantitative nicotine analyses have the advantage
of being specific to TS exposure (8). In this study,
both current and passive smokers were evaluated.
Passive smoking is also called secondhand smoking
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(SHS), environmental tobacco smoking (ETS), or
involuntary smoking. SHS involves the smoke of a
smoldering tobacco product and the exhaled breath
of a smoking individual, and SHS exposure is a
worldwide public health problem (10,11).
The measurement of SHS exposure may be useful
in identifying occupational risks resulting in potential
health problems. eCO, cotinine, and nicotine are
useful biomarkers for measuring SHS exposure (1216).
The passive smoking rate in Turkey was reported
as 67.0%-97.4% (17,18). The SHS rate can be
determined more accurately by measuring the
concentration of nicotine in hair, cotinine in urine, or
eCO. In this study, we aimed to detect and compare
the HN concentrations and eCO levels in active and
passive smokers and subjects without TS exposure,
and to determine the cutoff values for these markers
in smokers and nonsmokers.
Materials and methods
Subjects
A total of 96 healthy subjects (64 male, 32 female)
were enrolled in the study. The subjects were divided
into 3 groups according smoking status and SHS,
and none of the subjects worked in a pub, bar, cafe,
or Turkish coffeehouse (19), which could cause
intensive exposure to TS.
Group 1 (n = 46) consisted of current smokers.
Group 2 (n = 20) consisted of people who were
nonsmokers within the last year but who had
SHS exposure of more than 3 h daily for at least 1
year in some microenvironments, including their
homes, neighbor’s homes, workplaces, or Turkish
coffeehouses.
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Group 3 (n = 30) consisted of people who were
nonsmokers within the last year, without any SHS
exposure.
The Fagerström Test for Nicotine Dependence
(FTND) was administered to all of the smokers.
The study protocol was approved by the local
ethics committee of Gaziosmanpaşa University
Hospital and informed consent was obtained from
all of the participants.
Exhaled CO measurement
eCO levels were measured by the single breath
method using a breath carbon monoxide monitor
(Micro 4 Smokerlyzer, Bedfont Scientific Ltd.,
UK). The subjects were instructed to take a deep
breath, hold their breath, and exhale fully into the
mouthpiece of the detector.
Hair sampling
Undyed or unbleached hair samples that had
retained their natural color were used. The hair from
the vertex of the scalp was cut as close to the skin as
possible and placed in a paper envelope. The collected
samples were stored at 4 °C.
Nicotine extraction in hair
The analytical method was an adaptation of the
procedure used by Zahlsen and Nilsen in 1990 (20).
The hair samples (8-10 mg) were incubated in 5 M
NaOH (3 mL) (Climax, Turkey) at 30 °C for 24 h.
After incubation, 1 mL of 99% dichloromethane
solution (Merck, Germany) was added to each
sample and samples were then vortexed for 2 min.
The upper organic phase was separated and then 100
μL of 99.5% n-butanol solution (Merck) was added
to make a final volume of 100 μL. The solvent was
removed by nitrogen gases, transferred to a vial using
an inserter, and analyzed by gas chromatographymass spectrometry (GC-MS). The simplified GCMS assay is sensitive and applicable for routine
screening of chronic SHS exposure in populationbased epidemiologic studies (21). Analyses were
carried out using a PerkinElmer Clarus 500 gas
chromatograph/mass spectrometer (USA). The GCMS oven temperature program was regulated as
follows: the initial temperature was set at 50 °C and
raised at a rate of 5 °C/min up to 180 °C, which was
maintained for 4 min. Afterwards, the temperature

was raised again at a rate of 20 °C/min to 250 °C and
held at that level for 10 min. As a carrier gas, 5 μL of
helium at a rate of 1 mL/min was injected into the
columns using a splitless mode. The column BPX5
had a film thickness of 30 m × 0.25 mm × 250 μm.
For the quantification of nicotine in hair samples,
concentrations of standard nicotine at 0.01 ppm,
1.00 ppm, and 10.00 ppm were analyzed by GC-MS.
A calibration curve with an R2 value of 0.99948 was
obtained. Quantitative determination of nicotine was
carried out based on peak area measurements.
Statistical analysis
All of the continuous variables had normal
distribution according to the Kolmogorov-Smirnov
normality test. One-way ANOVA and 2 independent
sample t-tests were used to compare the continuous
variables. For multiple comparisons, the least
significant differences test was used. Continuous
variables were presented as arithmetic means (mean)
and standard deviations (SD). Correlation analysis
was used to determine the relation of eCO and
HN with smoking properties. Receiver operating
characteristics (ROC) curve analysis was used to
determine the cutoff value of CO according to
smoking status. P < 0.05 was considered statistically
significant. Statistical analysis was performed using
commercially available software (PASW 18, SPSS
Inc., USA).
Results
A total of 96 subjects (64 male, 32 female) in 3 groups
were included in the study. The mean age of all of the
subjects was 39.1 ± 12.0 years.
Group 1 included 46 subjects (35 male, 11 female)
with a mean age of 36.1 ± 8.3 years, who had smoked
20.6 ± 11.8 pack-years. Twenty (43.5%) had smoked
≥20 pack-years, and 26 (56.5%) smoked more than
20 cigarettes per day. The mean FTND score was 6.4
± 2.0.
Group 2 included 20 subjects (14 male, 6 female)
with a mean age of 37.4 ± 10.1 years.
The mean age of the subjects in Group 3 (14 male,
12 female) was 44.8 ± 15.7 years.
The eCO levels of all of the subjects were measured
and the levels were higher in the smokers than in the
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nonsmokers. The eCO levels were similar in Group
2 and Group 3 (Table). The HN concentrations of 47
of the subjects (18 subjects in Group 1, 15 subjects in
Group 2, and 14 subjects in Group 3) were measured.
The mean HN concentration was higher in Group 1
than in the other groups, but similar in Group 2 and
Group 3 (Table).

30

HN concentration (ng/mg)

25

The mean levels of eCO and HN were similar
in the smokers who smoked ≥20 cigarettes per day
compared to those who smoked <20 cigarettes per
day. No significant correlation between the levels of
eCO and HN and the number of cigarettes smoked
per day, pack-years, or FTND scores were found
among the smokers.
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It was reported that smokers had higher mean HN
levels than nonsmokers (12,21-23). In the literature,
there are different results for the HN levels of
smokers (33.9 μg/g, 38.3 μg/g, 30.6 μg/g, and 39.0 ng/
mg) and nonsmokers (0.006 μg/g, 1.8 μg/g, 4.5 μg/g,
and 2.5 ng/mg) (19,22,24,25). Man et al. reported
mean concentrations of HN in active smokers, SHSexposed nonsmokers, and unexposed nonsmokers
as 26.3 ng/mg, 2.9 ng/mg, and 1.0 ng/mg (21). In
comparison, in the present study, a slightly lower
HN concentration was determined. In smokers,

Discussion
In this study, the HN concentration and eCO level
in different groups was investigated with the aim
of determining TS exposure. The eCO levels were
higher in the smokers than in the other groups,
regardless of the amount of cigarettes smoked per
day. The concentrations of HN were also higher in

Table. HN and eCO levels in the study groups.

P

eCO (ppm)
(mean ± SD)

Group 1

20.89 ± 19.65

Group 2

2.07 ± 0.67

Group 3

0.7 ± 0.3

1.0 ± 0.8

Smoker

20.89 ± 19.65

9.3 ± 5.1

1.41 ± 0.87

P

9.3 ± 5.1
<0.001

<0.001

1.3 ± 1.3

1.1 ± 1.0

<0.001*

<0.001

* According to pairwise comparison, there was a statistically significant difference between smokers and
the other 2 groups. The HN concentrations were similar in Group 2 and Group 3.
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the smokers than in the other groups. However, the
eCO and HN levels were not sufficiently different to
distinguish subjects with or without SHS exposure.

According to the ROC curve analysis, the cutoff
value for eCO was determined as 1.5 ppm for
nonsmokers and 6 ppm for smokers. The cutoff value
of HN concentration, which distinguishes smokers
from nonsmokers, was 4 ng/mg.

Nonsmoker

18

Figure. Correlation between the levels of eCO and HN
concentration.

A significant positive correlation was found
between the levels of eCO and the concentration of
HN (r = 0.432, P < 0.002) (Figure).

HN (ng/mg)
(mean ± SD)

16
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the minimal and maximal HN concentrations were
6.0 ng/mg and 94.8 ng/mg, respectively. The large
variations in nicotine concentrations may be due
to many different factors such as exposure to SHS,
exposure time, distance from the source of exposure,
and differences in ventilation status (26,27).
Kintz et al. reported that 2 ng/mg of HN can be
used to distinguish smokers from nonsmokers (22).
In another study, the cutoff value was defined as 2-5
ng/mg HN for smokers (23). In our study, the cutoff
value of HN concentration for smokers was within
this range. The concentrations of HN were similar in
subjects exposed or unexposed to SHS. It should be
noted again that none of the subjects work in a pub,
bar, cafe, or Turkish coffeehouse, which would cause
intensive exposure to TS. Moreover, this result may be
associated with some individual properties like hair
growth, color, and nicotine absorption, which affect
the concentration of HN (8,26-28); the duration and
intensity of exposure of TS; the distance from the
source of the TS; and differences in ventilation status.
Prior studies have found that HN level is associated
with the number of cigarettes smoked per day.
Eliopoulos et al. reported that higher HN levels were
associated with an increased number of cigarettes
smoked per day (29). Our results did not support
their findings; namely, we could not detect an impact
of the number of cigarettes smoked per day on HN
concentrations, as was also the case in a study by AlDelaimy et al. (30). This result may be associated with
individual properties of hair and the intensity and
duration of exposure, as noted previously. The range
variation of HN concentrations of smokers may be
another reason for the similar finding.
eCO is one of the most common measures used to
quantify tobacco exposure (4). It is used to confirm
smoking status in smoking cessation programs (31).
The mean levels of eCO were reported as 9.5-21.6
ppm in smokers and 1.3-4.3 ppm in nonsmokers (16,
13,31-33). In our study, the mean levels of eCO were
9.3 ppm in smokers and 1.1 ppm in nonsmokers.
Although it is used to confirm smoking status, the
cutoff level is still a matter of debate (31). Middleton
et al. (13) and Deveci et al. (16) proposed the use of
6 ppm and 6.5 ppm as the cutoff breath CO levels
in smokers and nonsmokers, respectively. We
determined similar cutoff values.

In different studies, the levels of eCO in passive
smokers were reported as 1.2-3 ppm (33-36). These
different results may be associated with the difference
in exposure time, the number of smokers implicated
for SHS exposure, the distance from the source of
the exposure, and ventilation status. In our study, the
mean level of eCO in cases with ETS exposure was
compatible with those found in the literature.
The eCO level depends on the number of
cigarettes smoked per day (37,38). Deveci et al.
reported a significant positive correlation between
eCO levels and daily cigarette consumption (16). In
our study, there was no correlation between the levels
of eCO and the number of cigarettes smoked per day.
Although Temel et al. found a positive correlation
in smokers of pack-years and FTND scores with the
levels of eCO, we did not find same relations (35).
We found a positive correlation between eCO
levels and HN concentrations, and we could not
find any study to evaluate these 2 parameters in the
current literature. However, Underner et al. reported
a significant correlation between eCO and urinary
cotinine (39). Fritz et al. determined that eCO
measurements are nearly as sensitive as the urinary
cotinine level for detecting smoking status (40).
Although nicotine analysis in some biological
samples like hair is specific to TS exposure, these
methods are expensive and difficult procedures.
In our study, the correlation between the levels of
eCO and HN concentrations suggests that instead
of HN analysis, a cheap and easy method like eCO
measurement may be used, but further studies with
more subjects are needed.
For distinguishing smokers and nonsmokers, a
HN concentration of 4 ng/mg and an eCO level of 6
ppm can be used as cutoff values.
We could not find any effect of TS exposure in
nonsmokers on the quantities of eCO and HN, but
it should be noted again that none of these subjects
worked in a pub, bar, cafe, or Turkish coffee house,
which can cause intensive exposure to TS.
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